lobbying_activities: 2106372
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2106372 | df830306-dd9d-41ab-9141-1fdb50755816 | Q1 | ENLISTED ASSOCIATION OF THE NATIONAL GUARD OF THE UNITED STATES | 46131 | ENLISTED ASSOCIATION OF THE NATIONAL GUARD OF THE UNITED STATES | 2018 | first_quarter | VET | FY18 Omnibus Defense and MILCON-VA bills Direct Report Language. Rare cancers. --- The disproportionate impact of rare cancers on veterans, the number of rare cancers affecting veterans that are understudied and misunderstood, and inadequate treatment options for rare cancers are concerning. Therefore, the Department is instructed to provide a report to the Committees within 90 days of enactment of this Act for each of the last five years: the prevalence rate ofrare cancers among veterans; the types of treatments being provided to veterans specifically for rare cancers; any studies on rare cancers conducted by the Department; the Department's expenditures on the treatment ofrare cancers; the Department's programs dedicated to addressing rare cancers among veterans; and recommendations on ways the Department can enhance rare cancer treatments for veterans. | Defense, Dept of (DOD),Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 10000 | 0 | 0 | 2018-04-16T13:01:20.973000-04:00 |